A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Clinical trial NCT00327691 · COMPLETED

Trial details

NCT number: NCT00327691
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Disease Cerebrovascular Accident Coronary Heart Disease

Start date: 1998-04-01
Enrollment: 8600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.